|
Name |
Secalonic acid D
|
Molecular Formula | C32H30O14 | |
IUPAC Name* |
methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-2-yl]-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
|
|
SMILES |
C[C@H]1CC(=O)C2=C(C3=C(C=CC(=C3O)C4=C(C5=C(C=C4)O[C@]6([C@@H]([C@H](CC(=O)C6=C5O)C)O)C(=O)OC)O)O[C@]2([C@@H]1O)C(=O)OC)O
|
|
InChI |
InChI=1S/C32H30O14/c1-11-9-15(33)21-25(37)19-17(45-31(21,27(11)39)29(41)43-3)7-5-13(23(19)35)14-6-8-18-20(24(14)36)26(38)22-16(34)10-12(2)28(40)32(22,46-18)30(42)44-4/h5-8,11-12,27-28,35-40H,9-10H2,1-4H3/t11-,12-,27+,28+,31+,32+/m0/s1
|
|
InChIKey |
NFZJAYYORNVZNI-OCHURCMPSA-N
|
|
Synonyms |
Secalonic acid D; 35287-69-5; HZP8L3M5ME; SECALONSAURE D; methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-2-yl]-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate; Secalonic acid D mycotoxin; dimethyl (5R,5'R,6S,6'S,10aR,10'aR)-1,1',5,5',8,8'-hexahydroxy-6,6'-dimethyl-9,9'-dioxo-5,5',6,6',7,7',9,9'-octahydro-10aH,10'aH-[2,2'-bixanthene]-10a,10'a-dicarboxylate; CCRIS 4937; SAD; UNII-HZP8L3M5ME; NSC 159631; NSC-159631; NSC-268922; ERGOCHROME EE; Ergochrome AA (2,2')-5-beta,6-alpha,10-beta-5',6'-alpha,10'-beta; (7,7'-Bi-4aH-xanthene)-4a,4'a-dicarboxylic acid, 2,2',3,3',4,4',9,9'-octahydro-1,1',4,4',8,8'-hexahydroxy-3,3'-dimethyl-9,9'-dioxo-, dimethyl ester, (3S-(3-alpha,4-beta,4a-beta,7(3'R,4'S,4'aS))); CHEMBL3740350; CHEBI:144225; (7,7'-BI-4AH-XANTHENE)-4A,4'A-DICARBOXYLIC ACID, 2,2',3,3',4,4',9,9'-OCTAHYDRO-1,1',4,4',8,8'-HEXAHYDROXY-3,3'-DIMETHYL-9,9'-DIOXO-, DIMETHYL ESTER, (3S-(3.ALPHA.,4.BETA.,4A.BETA.,7(3'R*,4'S*,4'AS*)))-; Secalonic acid D 50 microg/mL in Chloroform; Q27095651; (7,7'-BI-4AH-XANTHENE)-4A,4'A-DICARBOXYLIC ACID, 2,2',3,3',4,4',9,9'-OCTAHYDRO-1,1',4,4',8,8'-HEXAHYDROXY-3,3'-DIMETHYL-9,9'-DIOXO-, DIMETHYL ESTER, (3S,3'S,4R,4'R,4AR,4'AR)-; methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,8-trihydroxy-10a-methoxycarbonyl-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl]-1,4,8-trihydroxy-3-methyl-9-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
|
|
CAS | 35287-69-5 | |
PubChem CID | 73431 | |
ChEMBL ID | CHEMBL3740350 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 638.6 | ALogp: | 3.1 |
HBD: | 6 | HBA: | 14 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 227.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 46 | QED Weighted: | 0.266 |
Caco-2 Permeability: | -5.856 | MDCK Permeability: | 0.00000874 |
Pgp-inhibitor: | 0.59 | Pgp-substrate: | 0.996 |
Human Intestinal Absorption (HIA): | 0.672 | 20% Bioavailability (F20%): | 0.044 |
30% Bioavailability (F30%): | 0.882 |
Blood-Brain-Barrier Penetration (BBB): | 0.008 | Plasma Protein Binding (PPB): | 86.27% |
Volume Distribution (VD): | 0.792 | Fu: | 7.71% |
CYP1A2-inhibitor: | 0.009 | CYP1A2-substrate: | 0.839 |
CYP2C19-inhibitor: | 0.012 | CYP2C19-substrate: | 0.204 |
CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.107 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.133 |
CYP3A4-inhibitor: | 0.627 | CYP3A4-substrate: | 0.263 |
Clearance (CL): | 3.408 | Half-life (T1/2): | 0.041 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.965 |
Drug-inuced Liver Injury (DILI): | 0.962 | AMES Toxicity: | 0.023 |
Rat Oral Acute Toxicity: | 0.919 | Maximum Recommended Daily Dose: | 0.032 |
Skin Sensitization: | 0.069 | Carcinogencity: | 0.023 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.077 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000954 | 1.000 | D01XWG | 0.282 | ||||
ENC000983 | 1.000 | D0T5XN | 0.281 | ||||
ENC003816 | 0.879 | D07VLY | 0.278 | ||||
ENC003347 | 0.654 | D0C9XJ | 0.278 | ||||
ENC005885 | 0.649 | D01XDL | 0.276 | ||||
ENC003348 | 0.638 | D0FX2Q | 0.260 | ||||
ENC001991 | 0.628 | D07IPB | 0.254 | ||||
ENC001973 | 0.588 | D0J2NK | 0.250 | ||||
ENC003346 | 0.571 | D01UBX | 0.247 | ||||
ENC002105 | 0.552 | D0G3DL | 0.247 |